Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALEMBIC PHARMA vs ZYDUS LIFESCIENCES - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ALEMBIC PHARMA ZYDUS LIFESCIENCES ALEMBIC PHARMA/
ZYDUS LIFESCIENCES
 
P/E (TTM) x 32.2 34.2 94.1% View Chart
P/BV x 4.4 5.8 76.5% View Chart
Dividend Yield % 0.8 0.6 136.4%  

Financials

 ALEMBIC PHARMA   ZYDUS LIFESCIENCES
EQUITY SHARE DATA
    ALEMBIC PHARMA
Mar-23
ZYDUS LIFESCIENCES
Mar-23
ALEMBIC PHARMA/
ZYDUS LIFESCIENCES
5-Yr Chart
Click to enlarge
High Rs792495 160.1%   
Low Rs463319 145.1%   
Sales per share (Unadj.) Rs287.6170.3 168.9%  
Earnings per share (Unadj.) Rs17.419.8 88.0%  
Cash flow per share (Unadj.) Rs31.426.9 116.7%  
Dividends per share (Unadj.) Rs8.006.00 133.3%  
Avg Dividend yield %1.31.5 86.5%  
Book value per share (Unadj.) Rs222.3173.0 128.5%  
Shares outstanding (eoy) m196.561,012.20 19.4%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x2.22.4 91.3%   
Avg P/E ratio x36.120.6 175.3%  
P/CF ratio (eoy) x20.015.1 132.1%  
Price / Book Value ratio x2.82.4 120.0%  
Dividend payout %46.030.3 151.6%   
Avg Mkt Cap Rs m123,402412,144 29.9%   
No. of employees `000NANA-   
Total wages/salary Rs m11,69124,564 47.6%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m56,526172,374 32.8%  
Other income Rs m304,746 0.6%   
Total revenues Rs m56,557177,120 31.9%   
Gross profit Rs m6,77229,677 22.8%  
Depreciation Rs m2,7547,227 38.1%   
Interest Rs m5021,299 38.6%   
Profit before tax Rs m3,54625,897 13.7%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1265,878 2.1%   
Profit after tax Rs m3,42020,019 17.1%  
Gross profit margin %12.017.2 69.6%  
Effective tax rate %3.622.7 15.7%   
Net profit margin %6.111.6 52.1%  
BALANCE SHEET DATA
Current assets Rs m29,139100,082 29.1%   
Current liabilities Rs m16,40855,267 29.7%   
Net working cap to sales %22.526.0 86.6%  
Current ratio x1.81.8 98.1%  
Inventory Days Days1050 19.3%  
Debtors Days Days794 7.2%  
Net fixed assets Rs m31,498144,776 21.8%   
Share capital Rs m3931,012 38.8%   
"Free" reserves Rs m43,312174,146 24.9%   
Net worth Rs m43,705175,158 25.0%   
Long term debt Rs m00-   
Total assets Rs m60,637244,940 24.8%  
Interest coverage x8.120.9 38.5%   
Debt to equity ratio x00-  
Sales to assets ratio x0.90.7 132.5%   
Return on assets %6.58.7 74.3%  
Return on equity %7.811.4 68.5%  
Return on capital %9.315.5 59.6%  
Exports to sales %46.439.2 118.3%   
Imports to sales %12.111.9 101.6%   
Exports (fob) Rs m26,21067,577 38.8%   
Imports (cif) Rs m6,84620,544 33.3%   
Fx inflow Rs m26,21067,577 38.8%   
Fx outflow Rs m6,84620,544 33.3%   
Net fx Rs m19,36447,033 41.2%   
CASH FLOW
From Operations Rs m7,24026,888 26.9%  
From Investments Rs m-4,47611,712 -38.2%  
From Financial Activity Rs m-2,620-44,004 6.0%  
Net Cashflow Rs m144-5,338 -2.7%  

Share Holding

Indian Promoters % 69.1 75.0 92.2%  
Foreign collaborators % 0.5 0.0 -  
Indian inst/Mut Fund % 19.0 18.0 105.5%  
FIIs % 4.5 5.0 90.6%  
ADR/GDR % 0.0 0.0 -  
Free float % 30.4 25.0 121.5%  
Shareholders   85,212 306,495 27.8%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ALEMBIC PHARMA With:   DIVIS LABORATORIES    SUN PHARMA    CIPLA    DR. REDDYS LAB    MANKIND PHARMA    


More on ALEMBIC PHARMA vs Cadila Healthcare

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

ALEMBIC PHARMA vs Cadila Healthcare Share Price Performance

Period ALEMBIC PHARMA Cadila Healthcare S&P BSE HEALTHCARE
1-Day -0.15% 0.57% 1.18%
1-Month -4.30% 7.77% -0.75%
1-Year 105.43% 107.52% 61.82%
3-Year CAGR 0.89% 32.30% 18.16%
5-Year CAGR 13.56% 24.52% 19.79%

* Compound Annual Growth Rate

Here are more details on the ALEMBIC PHARMA share price and the Cadila Healthcare share price.

Moving on to shareholding structures...

The promoters of ALEMBIC PHARMA hold a 69.6% stake in the company. In case of Cadila Healthcare the stake stands at 75.0%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of ALEMBIC PHARMA and the shareholding pattern of Cadila Healthcare.

Finally, a word on dividends...

In the most recent financial year, ALEMBIC PHARMA paid a dividend of Rs 8.0 per share. This amounted to a Dividend Payout ratio of 46.0%.

Cadila Healthcare paid Rs 6.0, and its dividend payout ratio stood at 30.3%.

You may visit here to review the dividend history of ALEMBIC PHARMA, and the dividend history of Cadila Healthcare.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.